Rosemary Moore's research while affiliated with Peter MacCallum Cancer Centre and other places

What is this page?


This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (1)


Figure: Consent discussions between patients and investigators or clinicians are crucial for patient understanding Reprinted with permission of The Cancer Council, New South Wales, Australia.  
Improvement of Informed Consent and the Quality of Consent Documents
  • Literature Review
  • Full-text available

June 2008

·

6,360 Reads

·

324 Citations

The Lancet Oncology

·

Rosemary Moore

Guidelines on informed consent intend to protect patients and promote ethical research conduct. To give informed consent, individuals should understand the purpose, process, risks, benefits, and alternatives to research (or a proposed clinical intervention) and make a free, voluntary decision about whether to participate. Many participants have incomplete understanding of various features of clinical trials. Issues associated with the length, format, and language of documents for written informed consent are common. Here, we analyse the written consent form, particularly in the context of clinical research, and the discussions that take place between clinician or investigator and patient. We review strategies to improve consent forms, particularly the use of plain language. Recommendations are made on discussions between investigator and patient to improve participant comprehension and satisfaction with the informed-consent process.

Download
Share

Citations (1)


... As described by Sütterlin et al. [14], the challenge with consents is to provide an accurate yet simplified description(s) of what possible cybersecurity threats exist to those patients who are either considering an implantable electronic device or currently possess one. Most informed consents, on average, are standardly written at a sixth grade reading level so descriptions of risk may need to be adjusted accordingly [47]. Thus, communicating possible cyber risks at a language level (e.g., layman's terms), which allows for patients to comprehend the information, adds to the further challenges with the consent process especially since science, technology, and genetic personalization are constantly advancing [48]. ...

Reference:

Patient informed consent, ethical and legal considerations in the context of digital vulnerability with smart, cardiac implantable electronic devices
Improvement of Informed Consent and the Quality of Consent Documents

The Lancet Oncology